GenAI products need evidence before launch and after every meaningful change. This accelerator assesses whether test sets, rubrics, scoring, human review, thresholds, and release criteria are strong enough to support defensible decisions.
Mind the Gap!
Too many teams rely on demos and confidence instead of evaluation evidence. Without validation discipline, release decisions become subjective, quality risk rises, and scale gets harder to trust.
- Can we prove this GenAI product is ready for production, or are we relying on confidence without evidence?
- Where could weak test sets, rubrics, validation routines, or release thresholds create quality risk?
- Do we have the evaluation and validation discipline to make launch decisions defensible and repeatable?
Turn Evaluation Gaps Into Release Confidence
We pinpoint the evaluation and validation gaps that matter most and build a practical plan to strengthen evidence, standards, and release discipline.
- Identify key stakeholders
- Explore what “good” looks like
- Explore Real-World Use Cases
- Review Key Competencies
- Assess Your Readiness
- Add Comments for Context
- Define Group Readiness
- Identify Mis-Alignment
- Capture Group Themes
Plan
- Understand High-Impact Gaps
- Explore Gap Closure Options
- Prioritize For Impact & Effort
- Define Key Steps
- Align on Ownership
- Define Target Timeline
- Committed Target
- Stretch Goals
- Controls
- Execute your plan
- Mitigate Risks
- Validate Your Impact
- Identify Stakeholders
- Communicate Changes
- Action Feedback
- Re-baseline Readiness
- Select Next Gaps
- Update your readiness plan
Outcomes you can expect
See which evidence, coverage, and evaluation gaps matter most.
Align teams on the standards required for confident GenAI releases.
Prioritize the gaps most likely to slow releases or weaken quality.
Build the evidence foundation needed to ship, learn, and improve faster.
Increase release confidence while reducing delay, drift, and avoidable risk.
Frequently Asked Questions
- Who is this GenAI Evaluation & Validation readiness accelerator for?
Product, AI, engineering, risk, and QA teams making evidence-based launch and change decisions. - When should we assess our GenAI Evaluation & Validation readiness?
Assess before weak evaluation evidence turns launch decisions into opinion or debate. - How is this different from a standard QA review?
It covers GenAI-specific eval sets, rubrics, scoring, human review, and release criteria.
- What exactly gets assessed in GenAI Evaluation & Validation readiness?
We review eval sets, test design, scoring, human review, thresholds, and release criteria. - What inputs and artifacts should we bring into the accelerator?
Bring evaluation rubrics, test cases, outputs, defect logs, release criteria, and reviewer notes. - What will we receive at the end of the accelerator?
You get an evaluation-readiness view, priority gaps, and a validation-improvement plan.
- How long does the accelerator take?
Plan on roughly 12 weeks, from diagnosis through prioritized gap closure. - How do the three phases work in practice?
Diagnose evaluation gaps, align thresholds, then close the issues that most affect release confidence. - How hands-on is the 12-week period?
Hands-on enough to review tests, evidence, scoring, and launch decision criteria.
- Which teams should participate?
Include product, AI, engineering, QA, risk, compliance, legal, and support owners. - How much time should leaders and working teams expect to commit?
Sponsors join key decisions; working teams support diagnostics, reviews, and action planning. - How will the right teams work together during the accelerator?
Teams align on evaluation coverage, thresholds, evidence quality, and release decisions.
- What changes when GenAI Evaluation & Validation readiness improves?
Launch and change decisions become more defensible, repeatable, and trusted. - How quickly can we act on the findings?
Immediately. The accelerator prioritizes gaps leaders can act on right away. - What should we do after the readiness assessment is complete?
Prioritize test sets, rubrics, thresholds, human review, and evidence quality.